Transcend Capital Advisors LLC increased its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 7.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,798 shares of the semiconductor company’s stock after buying an additional 124 shares during the quarter. Transcend Capital Advisors LLC’s holdings in Synopsys were worth $873,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also bought and sold shares of the stock. State Street Corp grew its stake in shares of Synopsys by 1.7% in the 3rd quarter. State Street Corp now owns 6,948,473 shares of the semiconductor company’s stock worth $3,518,637,000 after acquiring an additional 119,057 shares in the last quarter. Geode Capital Management LLC grew its position in Synopsys by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 3,281,867 shares of the semiconductor company’s stock worth $1,656,005,000 after purchasing an additional 61,799 shares in the last quarter. Edgewood Management LLC increased its stake in Synopsys by 18.9% in the 3rd quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company’s stock valued at $1,554,540,000 after buying an additional 487,025 shares during the last quarter. Van ECK Associates Corp lifted its position in shares of Synopsys by 26.5% during the 3rd quarter. Van ECK Associates Corp now owns 1,605,001 shares of the semiconductor company’s stock worth $791,923,000 after buying an additional 335,993 shares in the last quarter. Finally, Parnassus Investments LLC bought a new position in shares of Synopsys during the 3rd quarter worth approximately $633,469,000. 85.47% of the stock is owned by hedge funds and other institutional investors.
Synopsys Stock Down 3.9 %
NASDAQ SNPS opened at $474.84 on Friday. The firm has a market cap of $73.40 billion, a P/E ratio of 32.70, a price-to-earnings-growth ratio of 3.23 and a beta of 1.12. The company’s 50 day moving average is $510.21 and its 200-day moving average is $517.35. Synopsys, Inc. has a 12-month low of $457.52 and a 12-month high of $629.38.
Insider Buying and Selling at Synopsys
Analyst Ratings Changes
SNPS has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “buy” rating and set a $640.00 price target on shares of Synopsys in a research report on Thursday, December 5th. Redburn Atlantic initiated coverage on Synopsys in a research report on Monday, January 13th. They set a “buy” rating and a $600.00 target price for the company. Rosenblatt Securities reiterated a “buy” rating and set a $635.00 target price on shares of Synopsys in a research note on Wednesday, December 4th. Loop Capital started coverage on shares of Synopsys in a research report on Monday, November 11th. They set a “buy” rating and a $675.00 price target for the company. Finally, Robert W. Baird lowered their price objective on shares of Synopsys from $644.00 to $630.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $641.82.
Read Our Latest Research Report on SNPS
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading
- Five stocks we like better than Synopsys
- Top Biotech Stocks: Exploring Innovation Opportunities
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- What Are Earnings Reports?
- DuPont’s Electronics Spinoff: The Start of Something Big
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.